Historical Valuation
Viemed Healthcare Inc (VMD) is now in the Undervalued zone, suggesting that its current forward PE ratio of 12.69 is considered Undervalued compared with the five-year average of 25.93. The fair price of Viemed Healthcare Inc (VMD) is between 9.91 to 17.23 according to relative valuation methord. Compared to the current price of 7.23 USD , Viemed Healthcare Inc is Undervalued By 27.05%.
Relative Value
Fair Zone
9.91-17.23
Current Price：7.23
27.05%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Viemed Healthcare Inc (VMD) has a current Price-to-Book (P/B) ratio of 2.05. Compared to its 3-year average P/B ratio of 2.64 , the current P/B ratio is approximately -22.03% higher. Relative to its 5-year average P/B ratio of 2.76, the current P/B ratio is about -25.50% higher. Viemed Healthcare Inc (VMD) has a Forward Free Cash Flow (FCF) yield of approximately 1.96%. Compared to its 3-year average FCF yield of 2.26%, the current FCF yield is approximately -13.38% lower. Relative to its 5-year average FCF yield of 2.52% , the current FCF yield is about -22.12% lower.
P/B
Median3y
2.64
Median5y
2.76
FCF Yield
Median3y
2.26
Median5y
2.52
Competitors Valuation Multiple
AI Analysis for VMD
The average P/S ratio for VMD competitors is 0.40, providing a benchmark for relative valuation. Viemed Healthcare Inc Corp (VMD.O) exhibits a P/S ratio of 0.88, which is 119.04% above the industry average. Given its robust revenue growth of 23.98%, this premium appears sustainable.
Performance Decomposition
AI Analysis for VMD
1Y
3Y
5Y
Market capitalization of VMD increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of VMD in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is VMD currently overvalued or undervalued?
Viemed Healthcare Inc (VMD) is now in the Undervalued zone, suggesting that its current forward PE ratio of 12.69 is considered Undervalued compared with the five-year average of 25.93. The fair price of Viemed Healthcare Inc (VMD) is between 9.91 to 17.23 according to relative valuation methord. Compared to the current price of 7.23 USD , Viemed Healthcare Inc is Undervalued By 27.05% .
What is Viemed Healthcare Inc (VMD) fair value?
VMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Viemed Healthcare Inc (VMD) is between 9.91 to 17.23 according to relative valuation methord.
How does VMD's valuation metrics compare to the industry average?
The average P/S ratio for VMD's competitors is 0.40, providing a benchmark for relative valuation. Viemed Healthcare Inc Corp (VMD) exhibits a P/S ratio of 0.88, which is 119.04% above the industry average. Given its robust revenue growth of 23.98%, this premium appears sustainable.
What is the current P/B ratio for Viemed Healthcare Inc (VMD) as of Jan 10 2026?
As of Jan 10 2026, Viemed Healthcare Inc (VMD) has a P/B ratio of 2.05. This indicates that the market values VMD at 2.05 times its book value.
What is the current FCF Yield for Viemed Healthcare Inc (VMD) as of Jan 10 2026?
As of Jan 10 2026, Viemed Healthcare Inc (VMD) has a FCF Yield of 1.96%. This means that for every dollar of Viemed Healthcare Inc’s market capitalization, the company generates 1.96 cents in free cash flow.
What is the current Forward P/E ratio for Viemed Healthcare Inc (VMD) as of Jan 10 2026?
As of Jan 10 2026, Viemed Healthcare Inc (VMD) has a Forward P/E ratio of 12.69. This means the market is willing to pay $12.69 for every dollar of Viemed Healthcare Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Viemed Healthcare Inc (VMD) as of Jan 10 2026?
As of Jan 10 2026, Viemed Healthcare Inc (VMD) has a Forward P/S ratio of 0.88. This means the market is valuing VMD at $0.88 for every dollar of expected revenue over the next 12 months.